NIH CCR2 AAA Study

Summary

NIH CCR2 AAA Study is a clinical trial^[1].

Key Facts

• NIH CCR2 AAA Study is in the country of United States^[2].
• NIH CCR2 AAA Study's instance of is recorded as clinical trial^[3].
• NIH CCR2 AAA Study's start time is recorded as +2021-02-17T00:00:00Z^[4].
• NIH CCR2 AAA Study's end time is recorded as +2025-06-30T00:00:00Z^[5].
• NIH CCR2 AAA Study's sponsor is recorded as Washington University School of Medicine^[6].
• NIH CCR2 AAA Study's main subject is recorded as aneurysm^[7].
• NIH CCR2 AAA Study's main subject is recorded as aortic aneurysm^[8].
• NIH CCR2 AAA Study's number of participants is recorded as {'unit': '1', 'amount': '+50'}^[9].
• NIH CCR2 AAA Study's title is recorded as CCR2 Targeted Molecular Imaging and Treatment of Abdominal Aortic Aneurysms^[10].
• NIH CCR2 AAA Study's minimum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+40'}^[11].
• NIH CCR2 AAA Study's ClinicalTrials.gov ID is recorded as NCT04586452^[12].
• NIH CCR2 AAA Study's maximum age is recorded as {'unit': 'http://www.wikidata.org/entity/Q577', 'amount': '+80'}^[13].
• NIH CCR2 AAA Study's clinical trial phase is recorded as phase I clinical trial^[14].
• NIH CCR2 AAA Study's research site is recorded as Washington University School of Medicine^[15].
• NIH CCR2 AAA Study's research subject recruitment status is recorded as recruiting^[16].
• NIH CCR2 AAA Study's study type is recorded as interventional study^[17].